Table of Contents

2019-2024 Global Epinephrine Autoinjector Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Epinephrine Autoinjector Consumption 2014-2024
  • 2.1.2 Epinephrine Autoinjector Consumption CAGR by Region
• 2.2 Epinephrine Autoinjector Segment by Type
  • 2.2.1 0.30 mg
  • 2.2.2 0.15 mg
• 2.3 Epinephrine Autoinjector Consumption by Type
  • 2.3.1 Global Epinephrine Autoinjector Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Epinephrine Autoinjector Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Epinephrine Autoinjector Sale Price by Type (2014-2019)
• 2.4 Epinephrine Autoinjector Segment by Application
  • 2.4.1 Under 6 years
  • 2.4.2 6 to 12 years
  • 2.4.3 Over 12 years
• 2.5 Epinephrine Autoinjector Consumption by Application
  • 2.5.1 Global Epinephrine Autoinjector Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Epinephrine Autoinjector Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Epinephrine Autoinjector Sale Price by Application (2014-2019)

3 Global Epinephrine Autoinjector by Players

• 3.1 Global Epinephrine Autoinjector Sales Market Share by Players
  • 3.1.1 Global Epinephrine Autoinjector Sales by Players (2017-2019)
  • 3.1.2 Global Epinephrine Autoinjector Sales Market Share by Players (2017-2019)
• 3.2 Global Epinephrine Autoinjector Revenue Market Share by Players
  • 3.2.1 Global Epinephrine Autoinjector Revenue by Players (2017-2019)
  • 3.2.2 Global Epinephrine Autoinjector Revenue Market Share by Players (2017-2019)
• 3.3 Global Epinephrine Autoinjector Sale Price by Players
• 3.4 Global Epinephrine Autoinjector Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Epinephrine Autoinjector Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Epinephrine Autoinjector Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Epinephrine Autoinjector by Regions

• 4.1 Epinephrine Autoinjector by Regions
  • 4.1.1 Global Epinephrine Autoinjector Consumption by Regions
  • 4.1.2 Global Epinephrine Autoinjector Value by Regions
• 4.2 Americas Epinephrine Autoinjector Consumption Growth
• 4.3 APAC Epinephrine Autoinjector Consumption Growth
• 4.4 Europe Epinephrine Autoinjector Consumption Growth
• 4.5 Middle East & Africa Epinephrine Autoinjector Consumption Growth

5 Americas

• 5.1 Americas Epinephrine Autoinjector Consumption by Countries
  • 5.1.1 Americas Epinephrine Autoinjector Consumption by Countries (2014-2019)
  • 5.1.2 Americas Epinephrine Autoinjector Value by Countries (2014-2019)
• 5.2 Americas Epinephrine Autoinjector Consumption by Type
• 5.3 Americas Epinephrine Autoinjector Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Epinephrine Autoinjector Consumption by Countries
  • 6.1.1 APAC Epinephrine Autoinjector Consumption by Countries (2014-2019)
  • 6.1.2 APAC Epinephrine Autoinjector Value by Countries (2014-2019)
• 6.2 APAC Epinephrine Autoinjector Consumption by Type
• 6.3 APAC Epinephrine Autoinjector Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Epinephrine Autoinjector by Countries
  • 7.1.1 Europe Epinephrine Autoinjector Consumption by Countries (2014-2019)
  • 7.1.2 Europe Epinephrine Autoinjector Value by Countries (2014-2019)
• 7.2 Europe Epinephrine Autoinjector Consumption by Type
• 7.3 Europe Epinephrine Autoinjector Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Epinephrine Autoinjector by Countries
  • 8.1.1 Middle East & Africa Epinephrine Autoinjector Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Epinephrine Autoinjector Value by Countries (2014-2019)
• 8.2 Middle East & Africa Epinephrine Autoinjector Consumption by Type
• 8.3 Middle East & Africa Epinephrine Autoinjector Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Epinephrine Autoinjector Distributors
• 10.3 Epinephrine Autoinjector Customer

11 Global Epinephrine Autoinjector Market Forecast

• 11.1 Global Epinephrine Autoinjector Consumption Forecast (2019-2024)
• 11.2 Global Epinephrine Autoinjector Forecast by Regions
  • 11.2.1 Global Epinephrine Autoinjector Forecast by Regions (2019-2024)
  • 11.2.2 Global Epinephrine Autoinjector Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Epinephrine Autoinjector Forecast by Type
• 11.8 Global Epinephrine Autoinjector Forecast by Application

12 Key Players Analysis

• 12.1 Mylan
  • 12.1.1 Company Details
  • 12.1.2 Epinephrine Autoinjector Product Offered
  • 12.1.3 Mylan Epinephrine Autoinjector Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Mylan News
• 12.2 Sanofi
  • 12.2.1 Company Details
  • 12.2.2 Epinephrine Autoinjector Product Offered
  • 12.2.3 Sanofi Epinephrine Autoinjector Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Sanofi News
• 12.3 ALK Abello
  • 12.3.1 Company Details
  • 12.3.2 Epinephrine Autoinjector Product Offered
  • 12.3.3 ALK Abello Epinephrine Autoinjector Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 ALK Abello News
• 12.4 Impax
  • 12.4.1 Company Details
  • 12.4.2 Epinephrine Autoinjector Product Offered
  • 12.4.3 Impax Epinephrine Autoinjector Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Impax News

...

13 Research Findings and Conclusion

Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through a prescription by doctors. Each prescription comes with two auto-injectors in a set.

Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.

In the last several years, the development of Epinephrine Autoinjector industry is relative high with average production growth rate of 14.66%. In 2016, the global capacity of Epinephrine Autoinjector is nearly 8.35 million units and the actual production is about 6.8 million units.

North America, especially United States is the largest market of Epinephrine Autoinjector. In 2015, the North America Epinephrine Autoinjector still hold more than market share more than 93% in production market. On the other hand, North America also occupied 60% percent in the consumption volume market.

Though Europe and Asia Epinephrine Autoinjector industry is developing fast, the gap between production and consumption is still huge. So there are ten thousands of Epinephrine Autoinjector exporting from USA to Europe and Asia.

Corresponding with the fast growth of North America Epinephrine Autoinjector production, the price growth of Epinephrine Autoinjector is also huge. So the global Epinephrine Autoinjector production value market is also fast developing.

According to this study, over the next five years the Epinephrine Autoinjector market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 2460 million by 2024, from US$ 1630 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Epinephrine Autoinjector business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Epinephrine Autoinjector market by product type, application, key manufacturers and key regions and countries.

This study considers the Epinephrine Autoinjector value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
0.30 mg
0.15 mg
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Under 6 years
6 to 12 years
Over 12 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mylan
Sanofi
ALK Abello
Impax
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Epinephrine Autoinjector consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Epinephrine Autoinjector market by identifying its various subsegments.
Focuses on the key global Epinephrine Autoinjector manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Epinephrine Autoinjector with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Epinephrine Autoinjector submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.